SH
Shyamal Hitesh Bari
About Shyamal Hitesh Bari
Data last updated:
Shyamal Hitesh Bari is a Director at Unigrace Pharmaceuticals Private Limited (since 2016). The company operates in Chemicals. Unigrace Pharmaceuticals Private Limited reported revenue of ₹39,966 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unigrace Pharmaceuticals Private Limited U24299MH2016PTC279966 | Director | 13 Apr 2016 | 2016 | ₹39,966 (FY 2023) | Active |
Board colleagues of Shyamal Hitesh Bari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hitesh Chandrakant Bari | 07425644 | Unigrace Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shyamal Hitesh Bari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shyamal Hitesh Bari
Shyamal Hitesh Bari currently holds 1 directorship: Unigrace Pharmaceuticals Private Limited (Director, since 13 Apr 2016, revenue ₹39,966 (FY 2023)).
Shyamal Hitesh Bari was first appointed on 13 Apr 2016 as Director at Unigrace Pharmaceuticals Private Limited.
The current boards of Shyamal Hitesh Bari's companies include Hitesh Chandrakant Bari (Unigrace Pharmaceuticals Private Limited).